List of Tables
Table 1. Global HIV-1 RT Inhibitors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global HIV-1 RT Inhibitors Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global HIV-1 RT Inhibitors Market Competitive Situation by Manufacturers in 2024
Table 4. Global HIV-1 RT Inhibitors Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global HIV-1 RT Inhibitors Sales Market Share by Manufacturers (2020-2025)
Table 6. Global HIV-1 RT Inhibitors Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global HIV-1 RT Inhibitors Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market HIV-1 RT Inhibitors Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of HIV-1 RT Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of HIV-1 RT Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of HIV-1 RT Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of HIV-1 RT Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global HIV-1 RT Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV-1 RT Inhibitors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global HIV-1 RT Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global HIV-1 RT Inhibitors Sales by Region (2020-2025) & (K Units)
Table 18. Global HIV-1 RT Inhibitors Sales Market Share by Region (2020-2025)
Table 19. Global HIV-1 RT Inhibitors Sales by Region (2026-2031) & (K Units)
Table 20. Global HIV-1 RT Inhibitors Sales Market Share by Region (2026-2031)
Table 21. Global HIV-1 RT Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global HIV-1 RT Inhibitors Revenue Market Share by Region (2020-2025)
Table 23. Global HIV-1 RT Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global HIV-1 RT Inhibitors Revenue Market Share by Region (2026-2031)
Table 25. North America HIV-1 RT Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America HIV-1 RT Inhibitors Sales by Country (2020-2025) & (K Units)
Table 27. North America HIV-1 RT Inhibitors Sales by Country (2026-2031) & (K Units)
Table 28. North America HIV-1 RT Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America HIV-1 RT Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe HIV-1 RT Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe HIV-1 RT Inhibitors Sales by Country (2020-2025) & (K Units)
Table 32. Europe HIV-1 RT Inhibitors Sales by Country (2026-2031) & (K Units)
Table 33. Europe HIV-1 RT Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe HIV-1 RT Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific HIV-1 RT Inhibitors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific HIV-1 RT Inhibitors Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific HIV-1 RT Inhibitors Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific HIV-1 RT Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific HIV-1 RT Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America HIV-1 RT Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America HIV-1 RT Inhibitors Sales by Country (2020-2025) & (K Units)
Table 42. Latin America HIV-1 RT Inhibitors Sales by Country (2026-2031) & (K Units)
Table 43. Latin America HIV-1 RT Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America HIV-1 RT Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa HIV-1 RT Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa HIV-1 RT Inhibitors Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa HIV-1 RT Inhibitors Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa HIV-1 RT Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa HIV-1 RT Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global HIV-1 RT Inhibitors Sales (K Units) by Type (2020-2025)
Table 51. Global HIV-1 RT Inhibitors Sales (K Units) by Type (2026-2031)
Table 52. Global HIV-1 RT Inhibitors Sales Market Share by Type (2020-2025)
Table 53. Global HIV-1 RT Inhibitors Sales Market Share by Type (2026-2031)
Table 54. Global HIV-1 RT Inhibitors Revenue (US$ Million) by Type (2020-2025)
Table 55. Global HIV-1 RT Inhibitors Revenue (US$ Million) by Type (2026-2031)
Table 56. Global HIV-1 RT Inhibitors Revenue Market Share by Type (2020-2025)
Table 57. Global HIV-1 RT Inhibitors Revenue Market Share by Type (2026-2031)
Table 58. Global HIV-1 RT Inhibitors Price (US$/Unit) by Type (2020-2025)
Table 59. Global HIV-1 RT Inhibitors Price (US$/Unit) by Type (2026-2031)
Table 60. Global HIV-1 RT Inhibitors Sales (K Units) by Application (2020-2025)
Table 61. Global HIV-1 RT Inhibitors Sales (K Units) by Application (2026-2031)
Table 62. Global HIV-1 RT Inhibitors Sales Market Share by Application (2020-2025)
Table 63. Global HIV-1 RT Inhibitors Sales Market Share by Application (2026-2031)
Table 64. Global HIV-1 RT Inhibitors Revenue (US$ Million) by Application (2020-2025)
Table 65. Global HIV-1 RT Inhibitors Revenue (US$ Million) by Application (2026-2031)
Table 66. Global HIV-1 RT Inhibitors Revenue Market Share by Application (2020-2025)
Table 67. Global HIV-1 RT Inhibitors Revenue Market Share by Application (2026-2031)
Table 68. Global HIV-1 RT Inhibitors Price (US$/Unit) by Application (2020-2025)
Table 69. Global HIV-1 RT Inhibitors Price (US$/Unit) by Application (2026-2031)
Table 70. Merck & Co., Inc. Company Information
Table 71. Merck & Co., Inc. Description and Business Overview
Table 72. Merck & Co., Inc. HIV-1 RT Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Merck & Co., Inc. HIV-1 RT Inhibitors Product
Table 74. Merck & Co., Inc. Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK HIV-1 RT Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. GSK HIV-1 RT Inhibitors Product
Table 79. GSK Recent Developments/Updates
Table 80. Roche Company Information
Table 81. Roche Description and Business Overview
Table 82. Roche HIV-1 RT Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Roche HIV-1 RT Inhibitors Product
Table 84. Roche Recent Developments/Updates
Table 85. Mylan Laboratories Ltd. Company Information
Table 86. Mylan Laboratories Ltd. Description and Business Overview
Table 87. Mylan Laboratories Ltd. HIV-1 RT Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Mylan Laboratories Ltd. HIV-1 RT Inhibitors Product
Table 89. Mylan Laboratories Ltd. Recent Developments/Updates
Table 90. Gilead Sciences, Inc. Company Information
Table 91. Gilead Sciences, Inc. Description and Business Overview
Table 92. Gilead Sciences, Inc. HIV-1 RT Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Gilead Sciences, Inc. HIV-1 RT Inhibitors Product
Table 94. Gilead Sciences, Inc. Recent Developments/Updates
Table 95. Janssen Services, LLC Company Information
Table 96. Janssen Services, LLC Description and Business Overview
Table 97. Janssen Services, LLC HIV-1 RT Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Janssen Services, LLC HIV-1 RT Inhibitors Product
Table 99. Janssen Services, LLC Recent Developments/Updates
Table 100. Bristol Myers Squibb Co. Company Information
Table 101. Bristol Myers Squibb Co. Description and Business Overview
Table 102. Bristol Myers Squibb Co. HIV-1 RT Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Bristol Myers Squibb Co. HIV-1 RT Inhibitors Product
Table 104. Bristol Myers Squibb Co. Recent Developments/Updates
Table 105. Pfizer Inc. Company Information
Table 106. Pfizer Inc. Description and Business Overview
Table 107. Pfizer Inc. HIV-1 RT Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Pfizer Inc. HIV-1 RT Inhibitors Product
Table 109. Pfizer Inc. Recent Developments/Updates
Table 110. Aidea Pharma Company Information
Table 111. Aidea Pharma Description and Business Overview
Table 112. Aidea Pharma HIV-1 RT Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Aidea Pharma HIV-1 RT Inhibitors Product
Table 114. Aidea Pharma Recent Developments/Updates
Table 115. Hansoh Pharma Company Information
Table 116. Hansoh Pharma Description and Business Overview
Table 117. Hansoh Pharma HIV-1 RT Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Hansoh Pharma HIV-1 RT Inhibitors Product
Table 119. Hansoh Pharma Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. HIV-1 RT Inhibitors Distributors List
Table 123. HIV-1 RT Inhibitors Customers List
Table 124. HIV-1 RT Inhibitors Market Trends
Table 125. HIV-1 RT Inhibitors Market Drivers
Table 126. HIV-1 RT Inhibitors Market Challenges
Table 127. HIV-1 RT Inhibitors Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of HIV-1 RT Inhibitors
Figure 2. Global HIV-1 RT Inhibitors Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global HIV-1 RT Inhibitors Market Share by Type: 2024 & 2031
Figure 4. Nucleoside Reverse Transcriptase Inhibitors Product Picture
Figure 5. Non-nucleoside Reverse Transcriptase Inhibitors Product Picture
Figure 6. Global HIV-1 RT Inhibitors Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global HIV-1 RT Inhibitors Market Share by Application: 2024 & 2031
Figure 8. HIV Infection
Figure 9. Hepatitis B
Figure 10. Global HIV-1 RT Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global HIV-1 RT Inhibitors Market Size (2020-2031) & (US$ Million)
Figure 12. Global HIV-1 RT Inhibitors Sales (2020-2031) & (K Units)
Figure 13. Global HIV-1 RT Inhibitors Average Price (US$/Unit) & (2020-2031)
Figure 14. HIV-1 RT Inhibitors Report Years Considered
Figure 15. HIV-1 RT Inhibitors Sales Share by Manufacturers in 2024
Figure 16. Global HIV-1 RT Inhibitors Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest HIV-1 RT Inhibitors Players: Market Share by Revenue in HIV-1 RT Inhibitors in 2024
Figure 18. HIV-1 RT Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global HIV-1 RT Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America HIV-1 RT Inhibitors Sales Market Share by Country (2020-2031)
Figure 21. North America HIV-1 RT Inhibitors Revenue Market Share by Country (2020-2031)
Figure 22. United States HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe HIV-1 RT Inhibitors Sales Market Share by Country (2020-2031)
Figure 25. Europe HIV-1 RT Inhibitors Revenue Market Share by Country (2020-2031)
Figure 26. Germany HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific HIV-1 RT Inhibitors Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific HIV-1 RT Inhibitors Revenue Market Share by Region (2020-2031)
Figure 33. China HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Southeast Asia HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Latin America HIV-1 RT Inhibitors Sales Market Share by Country (2020-2031)
Figure 41. Latin America HIV-1 RT Inhibitors Revenue Market Share by Country (2020-2031)
Figure 42. Mexico HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Brazil HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Argentina HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Middle East and Africa HIV-1 RT Inhibitors Sales Market Share by Country (2020-2031)
Figure 46. Middle East and Africa HIV-1 RT Inhibitors Revenue Market Share by Country (2020-2031)
Figure 47. Turkey HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. UAE HIV-1 RT Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Global Sales Market Share of HIV-1 RT Inhibitors by Type (2020-2031)
Figure 51. Global Revenue Market Share of HIV-1 RT Inhibitors by Type (2020-2031)
Figure 52. Global HIV-1 RT Inhibitors Price (US$/Unit) by Type (2020-2031)
Figure 53. Global Sales Market Share of HIV-1 RT Inhibitors by Application (2020-2031)
Figure 54. Global Revenue Market Share of HIV-1 RT Inhibitors by Application (2020-2031)
Figure 55. Global HIV-1 RT Inhibitors Price (US$/Unit) by Application (2020-2031)
Figure 56. HIV-1 RT Inhibitors Value Chain
Figure 57. Channels of Distribution (Direct Vs Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
